Marshall Wace
AMLX icon

Marshall Wace’s Amylyx Pharmaceuticals AMLX Stock Holding History

Marshall Wace’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-247,275
Closed -$875K – 2669
2025
Q1 		$875K Buy
247,275
+62,597
+34% +$223K ﹤0.01% 1846
2024
Q4 		$698K Sell
184,678
-99,308
-35% -$467K ﹤0.01% 1896
2024
Q3 		$920K Buy
+283,986
New +$638K ﹤0.01% 1682
2024
Q1 		– Sell
-985,114
Closed -$14.5M – 2411
2023
Q4 		$14.5M Sell
985,114
-212,646
-18% -$3.26M 0.03% 576
2023
Q3 		$21.9M Sell
1,197,760
-782,420
-40% -$16.5M 0.05% 407
2023
Q2 		$42.7M Buy
1,980,180
+840,940
+74% +$22.7M 0.09% 261
2023
Q1 		$33.4M Buy
+1,139,240
New +$39.6M 0.08% 304
2022
Q4 		– Sell
-341,064
Closed -$9.6M – 2916
2022
Q3 		$9.6M Sell
341,064
-317,309
-48% -$7.92M 0.02% 918
2022
Q2 		$12.7M Buy
658,373
+73,909
+13% +$877K 0.03% 705
2022
Q1 		$7.51M Buy
+584,464
New +$13.2M 0.02% 1076

Other funds holding AMLX

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
6CM
683 Capital Management New York $1.08B AUM 85.52% 1-Year Est. Return